Drug intelligence / Profile preview

GRB-H

Development stage
Preclinical
Administration
Topical
01

Overview

GRB-H is a $\lambda$-carrageenan-enriched sulfated hybrid galactan isolated from the marine red alga *Gigartina radula*. It is a complex polysaccharide composed of $\kappa$-, $\iota$-, $\mu$-, $\nu$-, and $\lambda$-carrageenan structural units. GRB-H is being investigated as a marine-derived candidate for the topical management of atopic dermatitis (AD). Its therapeutic potential is driven by coordinated local anti-inflammatory and systemic immunomodulatory actions. In preclinical models, GRB-H has demonstrated the ability to suppress pro-inflammatory cytokines, reduce nitric oxide (NO) production, lower serum IgE levels, and restore the Th1/Th2 immune balance. Topical application has been shown to ameliorate skin inflammation, epidermal hyperplasia, and dermal immune cell infiltration in murine models of AD.

Other names
lambda-carrageenan-enriched sulfated hybrid galactanGigartina radula galactan
02

Targets

IL-6 (Interleukin 6)TNFA (Tumor necrosis factor alpha (soluble))IFNG (Interferon gamma)IL1B (Interleukin-1 beta)IL-4 (Interleukin 4)IL-5 (Interleukin 5)IL31 (IL-31)

Beyond the preview

Go deeper on GRB-H.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on GRB-H.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call